Comment on “Antihyperglycemic Drugs and Risk of Asthma Exacerbation in Patients With Asthma and Type 2 Diabetes: A Multinational Retrospective Cohort Study”
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2026-11 · 46 (11)
DOI: 10.1002/phar.70211 ↗Kurz gefasst
Leserbrief in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 27.10.2026. Verfasst von Xiang Ma und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiration, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China. Die Arbeit nennt 3 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Respiration, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, China.
ORCID-Profile: Xiang Ma
Zitieren
APA
Ma, X., & Shan, Q. (2026). Comment on “Antihyperglycemic Drugs and Risk of Asthma Exacerbation in Patients With Asthma and Type 2 Diabetes: A Multinational Retrospective Cohort Study”. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 46(11). https://doi.org/10.1002/phar.70211
Vancouver
Ma X, Shan Q. Comment on “Antihyperglycemic Drugs and Risk of Asthma Exacerbation in Patients With Asthma and Type 2 Diabetes: A Multinational Retrospective Cohort Study”. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2026;46(11). doi:10.1002/phar.70211
BibTeX
@article{Ma2026,
author = {Ma, Xiang and Shan, Qingqing},
title = {Comment on “Antihyperglycemic Drugs and Risk of Asthma Exacerbation in Patients With Asthma and Type 2 Diabetes: A Multinational Retrospective Cohort Study”},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2026},
volume = {46},
number = {11},
doi = {10.1002/phar.70211}
}
EUVIMED